Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde

US8273797B2 · kind B2 · utility

Assignee

• The United States of America as Represented by the Secretary of the Department of Health and Human Services · US

Inventors

• Susan D. Mertins · Frederick, US
• Susan E. Bates · Bethesda, US
• David G. Covell · Bethesda, US
• Geoffrey W. Patton · Wheaton, US
• Melinda G. Hollingshead · Birmingham, US
• Rao Vishnuvajjalla · Rockville, US

Key dates

• Filing date: Jul 5, 2011
• Grant date: Sep 25, 2012
• Expiry date: Jul 5, 2031

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention features methods of treating a mammalian subject having renal cancer by administration of 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde. The present invention further features administration protocols and dosing schedules for methods of treating patients having renal cancer and pharmaceutical compositions suitable for use in the treatment methods provided herein.